Tag Archives: Julio Montaner

BC gives $5 million to expand hepatitis C efforts

BC gives $5 million to expand hepatitis C effortsApril 21, 2016 – The St. Paul’s Foundation, in collaboration with the BC Centre for Excellence in HIV/AIDS (BCCfE), the BC Centre for Disease Control (BCCDC), the Vancouver Coastal Health, and the University of British Columbia, has been given $5 million for a research study on how to reduce new infections of hepatitis C in BC.

The funding will be used to “help those at increased risk of re-infection with hepatitis C, by focusing on engagement with the health system, and it will help to evaluate the health outcomes with our current treatment regimens,” stated Health Minister Terry Lake at the morning announcement in Vancouver.

The research will focus on “individuals in Vancouver who have been successfully cured of hepatitis C, but who have been identified as at increased risk of re-infection. It will also evaluate the impact and outcomes of current hepatitis C treatments, and identify the next steps required to optimize treatment outcomes in B.C.” (BCCfE)

This hepatitis C research funding announcement was made today by the Health Minister Terry Lake and BC Centre for Excellence in HIV/AIDS (BCCfE)’s director Dr. Julio Montaner.

At the announcement, Dr. Mel Krajden, medical lead for hepatitis at the BC Centre for Disease Control, pointed out that “By understanding how to optimize treatment outcomes, we can maximize the individual and societal impact of these very promising therapies.” (BCCfE)

Links to More Information about the Announcement

Information from BCCfE’s press release

New BC hepatitis C treatment plans?

New BC hepatitis C treatment plans?In Vancouver’s Downtown Eastside yesterday, December 1st, B.C.’s Ministry of Health and Dr. Julio Montaner, Director of the British Columbia Centre for Excellence in HIV/AIDS, announced that they are looking to expand hepatitis C treatment in BC.

Their planned treatment expansion program, which is still in the discussion phase, will target core transmitters, those who’s lifestyles put them at risk for passing the virus on. The program will then work to treat others, sooner and in increased numbers, as treatment costs decrease.

Terry Lake, B.C.’s Minister of Health, stated Monday that “As we expand treatment and as the cost of those drugs come down, we will reach further upstream and treat more people, and treat them earlier.”

See the full Vancouver Sun article here.

Response to Treatment by Prevention Article

sq_trialsThe Globe and Mail article: B.C. medical researchers offer treatment by prevention for hepatitis C

PHCN recognizes treatment as prevention (TasP) as the strategy of choice for people who use injection/inhalation drugs, who, as a group, have the highest rate of new HCV infections. Treatment as prevention is an approach tailored to meet their specific health needs and we both support and advocate for that approach in all communities of the province.

That idea – specific approaches designed to meet the needs of specific populations – is what is critical in the drive to cure individuals and eradicate hepatitis C in BC.

The gap right now is a clearly thought-out and articulated strategy for reaching out to baby boomers, immigrant populations, and Aboriginal people, and engaging them in care, treatment, and support for hepatitis C. The other half of this picture is the health care system and providers within it. What is the strategy to build capacity – system and providers – to meet this urgent and acute population health demand?